MassChallenge
MassChallenge is a non-equity startup accelerator headquartered in Boston, Massachusetts, with additional locations in Israel, Mexico, Switzerland, Texas, and the UK. Founded in 2009, it focuses on fostering innovation and entrepreneurship by supporting high-potential startups across various industries globally. MassChallenge provides expert mentorship, a tailored curriculum, and access to corporate partners without taking any equity from the startups. Its programs, including specialized initiatives like MassChallenge FinTech and MassChallenge HealthTech, aim to facilitate partnerships between startups and established companies to drive innovation and growth. To date, MassChallenge has helped over 1,200 alumni raise more than $2 billion in funding and create over 65,000 jobs, demonstrating its significant impact on the global innovation ecosystem.
Non Equity Assistance in 2021
Femly LLC is a manufacturer and distributor of feminine hygiene care products, specializing in organic and environmentally friendly options. Founded in 2016 and based in Upper Marlboro, Maryland, the company offers a range of products including organic cotton tampons, day and night pads, and menstrual cups. Femly emphasizes the use of certified organic cotton, free from pesticides, to enhance women's health and comfort. In addition to its product line, Femly provides monthly subscription services, online ordering, and home delivery, ensuring convenience for its customers. The company also supplies feminine care products to restrooms in various organizations such as hotels, co-working spaces, and colleges, making its products widely accessible.
Non Equity Assistance in 2021
VecTech specializes in advanced mosquito and tick surveillance through a cloud-connected system of smart traps. These traps capture mosquito specimens, which are then imaged and automatically analyzed using AI-based identification algorithms to classify them by genus and species. Each specimen is tagged with GPS coordinates, and the collected data is displayed on a centralized dashboard for expert review. This innovative approach significantly reduces labor costs associated with traditional surveillance methods, enabling scientists and public health organizations to monitor mosquito populations more effectively. By providing timely and precise data, VecTech supports efforts to combat mosquito-borne diseases such as dengue and malaria, allowing for early detection of potential outbreaks and tailored interventions.
Non Equity Assistance in 2020
Relavo, LLC is a medical device company founded in 2018 and based in Baltimore, Maryland. The company focuses on developing solutions to prevent infection related to peritoneal dialysis, specifically through its product, The PeritoneX. This device disinfects contamination points prior to the initiation of dialysis treatment, thereby helping patients with kidney failure to lower their risk of developing peritonitis. By offering an affordable means to enhance safety during peritoneal dialysis, Relavo aims to improve patient outcomes in this critical area of healthcare.
Relavo, LLC is a medical device company founded in 2018 and based in Baltimore, Maryland. The company focuses on developing solutions to prevent infection related to peritoneal dialysis, specifically through its product, The PeritoneX. This device disinfects contamination points prior to the initiation of dialysis treatment, thereby helping patients with kidney failure to lower their risk of developing peritonitis. By offering an affordable means to enhance safety during peritoneal dialysis, Relavo aims to improve patient outcomes in this critical area of healthcare.
Non Equity Assistance in 2020
Developer of a single-use graft preparation system designed to assist in cornea transplant. The company's system simplifies corneal tissue processing, improving yields and expanding the donor pool while maintaining high-quality grafts for transplants, enabling eye professionals to reduce costs and empower their capacity and efficacy.
Non Equity Assistance in 2018
Pinkaloo is on a mission to modernize charitable giving through our Modern Giving account, which merges the best of an HSA + Venmo for managing donations. In partnership with Employers and Financial Institutions, Pinkaloo’s software-as-a-service platform enables donors to better budget for their giving, helps donors discover charities and projects that match their passions, donate to any charity wherever and whenever they want, and come tax time centralizes all of their tax receipts in one place. For our customers, it is a turn-key solution that allows them to maximize engagement with their employees and customers and to power the philanthropy in the communities that they serve via our white-labeled giving accounts.
Non Equity Assistance in 2018
Multisensor Diagnostics (MDx), LLC, is a diversified health and wellness company primarily serving the high-acuity patients.
Non Equity Assistance in 2018
PYT Funds, Inc., a financial services company, provides an online platform to connect families with banks to provide loans for students. Its platform allows students to combine crowdfunding and student loans to pay for college. The company was founded in 2014 and is based in Washington, District of Columbia with additional offices in Wilmington, Delaware; Rockville, Maryland; and Richmond, Virginia.
Non Equity Assistance in 2017
Multisensor Diagnostics (MDx), LLC, is a diversified health and wellness company primarily serving the high-acuity patients.
PathoVax LLC is a biotechnology company based in Baltimore, Maryland, founded in 2014. It focuses on the development of RGVax, an innovative vaccine designed to protect against human papillomavirus (HPV). RGVax is notable for being the first low-cost HPV vaccine that targets all clinically relevant types, including all 15 oncogenic strains and additional skin HPV types. This broad-spectrum approach addresses the limitations of existing vaccines, which primarily focus on a limited number of cancer-causing strains and often face low uptake due to incomplete coverage and associated social stigma. Established animal studies have demonstrated the protective efficacy of RGVax, positioning it as a suitable childhood vaccine and offering the potential for significant early market entry in a segment that could see higher acceptance and usage rates.
Cogentis is committed to finding cures for a number of neurodegenerative diseases. Their groundbreaking research will lead to treatments for Alzheimer's disease, fronto-temporal dementia, progressive supranuclear palsy and more.
ARMR Systems LLC specializes in developing innovative wearable hemorrhage control systems aimed at enhancing the survivability of traumatic injuries on the battlefield, particularly in scenarios where immediate medical support is unavailable. Founded in 2014 and based in Baltimore, Maryland, the company offers effective standalone products and integrated solutions that equip warfighters and combat medics with advanced trauma care capabilities. Its systems feature an ergonomically designed harness and a tourniquet-style pressure device, which can rapidly compress damaged arteries in critical areas of the torso to mitigate blood loss. ARMR Systems is dedicated to collaboration, drawing from a multidisciplinary team to ensure diverse perspectives are utilized in problem-solving and technology development.
Tauros Engineering
Grant in 2013
Tauros Engineering was formed in 2013 to commercialize a revolutionary technology for the detection of bridge scour. Bridge scour is the erosion of earth around the foundation of a bridge and is the leading cause of bridge failure. Scour endangers public safety and can result in significant repair costs. Monitoring is required but current solutions do not provide accurate real-time detection. Their patent pending solution provides bridge owners with robust, accurate, 24/7 monitoring of scour.
ELF empowers underprivileged students in Sri Lanka to achieve greater access to education. As its main approach, ELF has developed a unique peer-to-peer Micro-Scholarship Model that connects sponsors from around the world with students, creating a sustainable funding source for the students' education. In addition, ELF focuses on other complementary models to provide a more holistic solution to the problem. ELF is also focused on replicating its scholarship model in other developing countries.
Enertaq provides a software service that integrates with existing Building Management Systems. They make slight adjustments in the timing of power consumption in buildings to promote electricity grid reliability, reduce carbon emissions and earn new revenue for building owners.
GentleMed creates the AccuEye to meet patient. What if you were one of the 60 Million people going blind because of Glaucoma? The precision of each drop is the difference between blindness and sight. In the U.S. alone, the glaucoma treatment market is worth $2.9 billion. Eye drops are easy to forget and difficult to apply. They have created the AccuEye to meet patients needs. Their low risk, Class I device has easy entry into the market. If half of todays non-compliant patients become compliant with AccuEye, healthcare will save $1B each year
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.